Your session is about to expire
← Back to Search
Improved Sleep for Obesity and Diabetes Risk Reduction
Study Summary
This trial aims to find a better sleep solution to help reduce diabetes and obesity risk.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this research project accepting new participants?
"Clinicialtrials.gov affirms that this clinical trial, which was originally published on the 1st of December 2023, is no longer recruiting participants. However, 383 other studies are currently looking for applicants."
Does the current protocol for this trial allow individuals over 30 to participate?
"According to the study's required qualifications, prospective participants must be between 21 and 50 years of age."
Who is the target population for this experiment?
"In order to be part of this study, individuals must have a body mass index that qualifies as obese and fall between the ages 21-50. The team is looking for 30 participants in total."
What aims does this investigation seek to accomplish?
"This clinical trial evaluates participants over the course of 24 days, with a primary outcome measure being Sleep Efficiency. Secondary outcomes include observed changes in sleepiness, appetite, and mood as reported by patients through a novel instrument; Oral Disposition Index (DIo) estimated from oral glucose tolerance tests; Insulinogenic Index determined via plasma insulin and glucose levels collected during an OGTT."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger